Impact of Impella5.0/5.5 use on short-term prognosis in patients with AMI-related cardiogenic shock receiving Impella-incorporated MCS in Japan

Back

ESC Professional Premium Access

Impact of Impella5.0/5.5 use on short-term prognosis in patients with AMI-related cardiogenic shock receiving Impella-incorporated MCS in Japan

Session: Updates on mechanical circulatory support

Topic: Cardiogenic Shock

Speaker: Doctor M. Nakamura (Toyama, JP)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Makiko Nakamura

University of Toyama, Toyama (Japan)

0 follower

9 more presentations in this session

Factors associated with 30-day mortality in patients receiving mechanical circulatory support for cardiogenic shock

Speaker: Miss M. Bogerd (Amsterdam, NL)

Direct comparison of mechanical circulatory support devices in porcine model of acute myocardial infarction complicated by ventricular septal defect and cardiogenic shock

Speaker: Professor P. Ostadal (Prague, CZ)

V-A ECMO weaning with pump-controlled retrograde trial off (PCRTO) approach: an illustration of safety, benefits and feasibility

Speaker: Doctor F. Fiorelli (London, GB)

Association between arterial oxygen tension with clinical outcomes in patients undergoing VA-ECMO support: a systematic review and dose-response meta-analysis

Speaker: Mr M. Ananta (Central Jakarta, ID)

Effectiveness of an Impella versus intra-aortic balloon pump in patients who received extracorporeal membrane oxygenation: a nationwide inpatient database study

Speaker: Doctor Y. Nishimoto (Toyonaka, JP)

Access the full session

Updates on mechanical circulatory support

Speakers: Doctor M. Nakamura, Miss M. Bogerd, Professor P. Ostadal, Doctor F. Fiorelli, Mr M. Ananta...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources